From a Bill Gates-backed startup in the mid ’90s to the Nobel stage in 2025, Fred Ramsdell reveals how “patient capital” and a mutation found in a 1940s mouse helped unlock immune system secrets. Read More
Mary Brunkow of the Seattle-based Institute for Systems Biology, Fred Ramsdell of Sonoma Biotherapeutics, and David Baker of the UW’s Institute for Protein Design were honored for their research. Read More
Seattle scientist Mary Brunkow of the Institute for Systems Biology (ISB) won a Nobel Prize for research on the immune cells that prevent our body from attacking itself. Read More
Sonoma Biotherapeutics on Wednesday announced that it received a $45 million payment from Regeneron Pharmaceuticals for meeting a significant milestone… Read More
The news: Sonoma Biotherapeutics is partnering with Regeneron to co-develop cell therapies for Crohn’s disease and other autoimmune conditions. The… Read More
Seattle and South San-Francisco based preclinical biotech company Sonoma Biotherapeutics has raised $265 million in new funding, the company announced… Read More
Don't miss a headline!
Sign up for GeekWire's newsletters today.
Thanks for subscribing!
Check your inbox to confirm your subscription.
